Sting Relief

1. Name Of The Medicinal Product

Sting Relief

2. Qualitative And Quantitative Composition

	%w/w
Benzyl alcohol Ph Eur	1.5
Chloroxylenol BP	1.5
Eucalyptus oil Ph Eur	1.0
Zinc oxide Ph Eur	2.0

3. Pharmaceutical Form

Cream

4. Clinical Particulars

4.1 Therapeutic Indications

Treatment of insect bites and stings, including bee and wasp stings and the bites of mosquitoes, gnats and other insects.

For topical administration to the skin.

4.2 Posology And Method Of Administration

Adults, children and elderly

Massage a little of the cream gently into the affected area.

Repeat the application every two or three hours if necessary.

4.3 Contraindications

Hypersensitivity to any of the ingredients.

4.4 Special Warnings And Precautions For Use

For external use only.

Keep all medicines out of the reach of children.

4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction

No clinically significant interactions known.

4.6 Pregnancy And Lactation

The safety of Sting Relief during pregnancy and lactation has not been established, but use of the product is not considered to be contraindicated during these periods.

4.7 Effects On Ability To Drive And Use Machines

No adverse effects known.

4.8 Undesirable Effects

Occasional hypersensitivity and irritant reactions.

4.9 Overdose

Over application to the skin may cause an irritant reaction. The use of Sting Relief should be immediately discontinued and symptomatic treatment provided.

In cases of oral ingestion, there may be burning in the gastrointestinal tract, nausea and vomiting. Treatment should be symptomatic and supportive. Only in severe cases would active therapy, including gastric aspiration and lavage, be necessary.

5. Pharmacological Properties

5.1 Pharmacodynamic Properties

Zinc oxide has mild astringent and soothing properties as well as being protective.

Benzyl alcohol is a weak local anaesthetic with disinfectant properties.

Chloroxylenol is an antiseptic with particular activity against gram positive organisms.

Eucalyptus oil has an irritant and rubefacient action which produces mild local anaesthesia.

5.2 Pharmacokinetic Properties

No data available

5.3 Preclinical Safety Data

There are no preclinical data of relevance to the prescriber which are additional to that already included.

6. Pharmaceutical Particulars

6.1 List Of Excipients

Japan wax

Liquid paraffin

Polawax

Purified water

6.2 Incompatibilities

None stated.

6.3 Shelf Life

36 months.

6.4 Special Precautions For Storage

None.

6.5 Nature And Contents Of Container

Collapsible aluminium tube, internally lacquered with an epoxy resin, with polyethylene caps or a collapsible aluminium tube internally lacquered with an epoxy resin with a membrane seal and a polyethylene or polypropylene cap with a piercer device.

Pack sizes: 14gm or 15gm.

The tube will be packed in a carton.

6.6 Special Precautions For Disposal And Other Handling

None stated.

7. Marketing Authorisation Holder

The Boots Company PLC

1 Thane Road West

Nottingham NG2 3AA

8. Marketing Authorisation Number(S)

PL 00014/0377

9. Date Of First Authorisation/Renewal Of The Authorisation

First Authorisation: 22 May 1989

Last Renewal: 15 September 1999

10. Date Of Revision Of The Text

May 2004